Actelis revenue plunges 60%, widens losses and warns of going‑concern amid funding fight

Actelis Networks, Inc. (NASDAQ: ASNS) - Quick read on what's happening inside the company

Short summary: Actelis is seeing a sharp revenue decline and widening losses, is burning cash, and remains in a financing and Nasdaq-compliance fight. Management has executed cost cuts and raised equity, but the company still reports substantial doubt about its ability to continue as a going concern.

Key facts & statistics (from Q2 2025 Form 10‑Q, USD in thousands)
- Revenues: Six months ended June 30, 2025 = 1,662 (thousands); Six months 2024 = 4,157
- Revenues (quarter): Q2 2025 = 941; Q2 2024 = 3,431
- Cost of revenues (six months): 1,106 (2025) vs 1,994 (2024)
- Gross profit (six months): 556 (2025) vs 2,163 (2024)
- Operating loss: Six months = (3,585); Q2 operating loss = (1,773)
- Net comprehensive loss: Six months = (3,761); Q2 = (1,901)
- Net loss per share (basic & diluted): Six months = (0.43); Q2 = (0.21)
- Adjusted EBITDA (six months): (3,473)
- Cash, cash equivalents and restricted cash (total): 695 (as of June 30, 2025)
- Cash & equivalents: 393; restricted cash equivalents (current): 302
- Trade receivables, net: 943 (allowance for credit losses $168)
- Inventories: 2,519 (write‑downs YTD = 92)
- Total assets: 5,982; Total liabilities: 4,730; Shareholders' equity: 1,024
- Accumulated deficit: (47,823)
- Current liabilities: 4,239 (includes credit line 236 and short‑term loan 305)
- Shares issued & outstanding: 9,540,221 (June 30, 2025); 11,292,114 as of Aug 12, 2025 (per filing)
- Warrants outstanding: 4,602,203 (as of June 30, 2025)
- Financing since quarter end: Private placement closed July 2, 2025 - gross proceeds ≈ $1.0 million (1,626,019 shares at $0.615 plus warrants)
- Employees: 38 total; 33 located in Israel (note: some employees called to reserve duty)

What's happening inside - facts and drivers
- Revenue decline is driven by the loss of a large renewal and a big deal in 2024 (Customer A was 52% of H1 2024 revenue and materially absent in H1 2025).
- North America sales tumbled: H1 2025 = 1,100 vs H1 2024 = 3,463.
- Management kept operating expense run‑rate roughly steady; R&D and sales & marketing rose modestly while G&A fell after cost reductions.
- Cash burn increased: net cash used in operating activities = (3,218) for six months 2025 (vs (2,343) in 2024).
- Company is actively raising capital (ATM sales in Q1/Q2 2025 and a July 2025 private placement) and issued warrants to lenders/placement agents.
- Management states substantial doubt about ability to continue as a going concern for at least one year absent additional financing.

Positive aspects of the income statement / operations
- Cost of revenues fell materially in absolute terms with lower sales (COGS six months: 1,106 vs 1,994), helping preserve gross margin given the revenue drop.
- General & administrative expense declined year‑over‑year (six months G&A 1,419 vs 1,607) - cost control is in place.
- Interest expense decreased (six months: 56 vs 344 in prior year) after partial loan repayments, lowering financial carrying cost.
- Company is able to raise capital: ATM sales in 2025 and a July 2025 private placement generated incremental cash and extended runway.

Negative aspects of the income statement / risks
- Revenues plunged ~60% YoY for the six‑month period (1,662 vs 4,157) - key demand deterioration and lost large customer(s).
- Gross profit collapsed (556 vs 2,163) and gross margin pressure remains because fixed costs cannot fall as fast as sales.
- Operating loss widened sharply (six months operating loss (3,585) vs (1,805) prior year) - losses driven mainly by revenue shortfall rather than expense explosions.
- Large net losses and steep negative adjusted EBITDA (-3,473 for six months) signal ongoing cash consumption.
- High customer concentration historically (Customer A dominated 2024) creates revenue volatility when large customers do not repeat purchases.
- Going‑concern disclosure and Nasdaq continued‑listing risks (noncompliance with minimum shareholders' equity; minimum bid price notification with deadline to regain compliance by Nov 10, 2025) increase execution pressure.

Near‑term catalysts and what to watch
- Cash & liquidity: monitor cash (695) + any post‑period receipts; runway depends on additional funding and collections.
- Financing outcomes: progress on planned financings (management mentioned a financing target by Sept 30, 2025) and any exercise of private placement warrants.
- Revenue momentum / pipeline: signs of new large orders, renewals, or re‑acceleration in North America and EMEA sales.
- Nasdaq compliance: evidence of regained shareholders' equity and maintaining minimum bid price before Nov 10, 2025.
- Gross margin improvements from product mix or cost reductions (management cites focus on margin mix and efficiencies).

Bottom line
Actelis (NASDAQ: ASNS) faces a clear execution challenge: sales fell sharply year‑over‑year, losses and cash burn widened, and liquidity remains tight despite recent financings. Management has taken cost actions and accessed capital markets, but the company remains dependent on near‑term financing, customer wins/renewals, and successful Nasdaq compliance to avoid further distress. Investors should watch cash balance, financing progress, and revenue signs closely.